Genelux Execs Trim Stakes as Insider Sales Continue—Is the Company Re‑evaluating Its Valuation?
Genelux insider sales reveal a cautious, gradual divestment plan, offering investors insight into leadership’s valuation strategy amid market uncertainty.
3 minutes to read